Benefits of fecal microbiota transplantation: A comprehensive review

A growing body of literatures showed the interaction of dysbiotic gut with a wide range of disorders, and the clinical use of fecal microbiota transplantation (FMT) shifted from infectious disease to non-communicable disorders. Despite the promising therapeutic benefits of FMT, the exact mechanisms...

Full description

Saved in:
Bibliographic Details
Main Author: Muluneh Ademe
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2020-10-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/12780
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148273389568000
author Muluneh Ademe
author_facet Muluneh Ademe
author_sort Muluneh Ademe
collection DOAJ
description A growing body of literatures showed the interaction of dysbiotic gut with a wide range of disorders, and the clinical use of fecal microbiota transplantation (FMT) shifted from infectious disease to non-communicable disorders. Despite the promising therapeutic benefits of FMT, the exact mechanisms through which fecal recipients benefit from the fecal intervention are not well understood. However, owing to the advantages of having a healthy gut microbiome, possible mechanisms of actions of FMT has been described. On the one hand, through direct ecological competition, FMT may potentially stimulate decolonization of pathogenic microorganisms and increase host resistance to pathogens. Moreover, following dysbiosis, abnormal microbial colonization of the gastrointestinal tract may also cause excessive or dysregulated immune response, resulting in chronic inflam­mation and the development of mucosal lesions. In this regard, repopulating gut microbiome through FMT helps to restore immune function and reduce host damage. On the other hand, FMT helps to restore essential metabolites used for host metabolism, including short-chain fatty acids (SCFA), antimicrobial peptides (AMP), bacteriocins and bile acids. Therefore, in this review, the existing evidences regarding the mechanisms of action, current opportunities and challenges of FMT will be described.
format Article
id doaj-art-e689d34463be47b9913918da30b0f2e2
institution OA Journals
issn 1972-2680
language English
publishDate 2020-10-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-e689d34463be47b9913918da30b0f2e22025-08-20T02:27:18ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802020-10-01141010.3855/jidc.12780Benefits of fecal microbiota transplantation: A comprehensive reviewMuluneh Ademe0Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia A growing body of literatures showed the interaction of dysbiotic gut with a wide range of disorders, and the clinical use of fecal microbiota transplantation (FMT) shifted from infectious disease to non-communicable disorders. Despite the promising therapeutic benefits of FMT, the exact mechanisms through which fecal recipients benefit from the fecal intervention are not well understood. However, owing to the advantages of having a healthy gut microbiome, possible mechanisms of actions of FMT has been described. On the one hand, through direct ecological competition, FMT may potentially stimulate decolonization of pathogenic microorganisms and increase host resistance to pathogens. Moreover, following dysbiosis, abnormal microbial colonization of the gastrointestinal tract may also cause excessive or dysregulated immune response, resulting in chronic inflam­mation and the development of mucosal lesions. In this regard, repopulating gut microbiome through FMT helps to restore immune function and reduce host damage. On the other hand, FMT helps to restore essential metabolites used for host metabolism, including short-chain fatty acids (SCFA), antimicrobial peptides (AMP), bacteriocins and bile acids. Therefore, in this review, the existing evidences regarding the mechanisms of action, current opportunities and challenges of FMT will be described. https://jidc.org/index.php/journal/article/view/12780Fecal transplantationColonization resistanceMechanismsStool bankChallenges
spellingShingle Muluneh Ademe
Benefits of fecal microbiota transplantation: A comprehensive review
Journal of Infection in Developing Countries
Fecal transplantation
Colonization resistance
Mechanisms
Stool bank
Challenges
title Benefits of fecal microbiota transplantation: A comprehensive review
title_full Benefits of fecal microbiota transplantation: A comprehensive review
title_fullStr Benefits of fecal microbiota transplantation: A comprehensive review
title_full_unstemmed Benefits of fecal microbiota transplantation: A comprehensive review
title_short Benefits of fecal microbiota transplantation: A comprehensive review
title_sort benefits of fecal microbiota transplantation a comprehensive review
topic Fecal transplantation
Colonization resistance
Mechanisms
Stool bank
Challenges
url https://jidc.org/index.php/journal/article/view/12780
work_keys_str_mv AT mulunehademe benefitsoffecalmicrobiotatransplantationacomprehensivereview